|
|
|
|
LEADER |
02995cam a2200589 a 4500 |
001 |
18779227 |
003 |
OCoLC |
005 |
20200430195401.0 |
008 |
880404s1988 dcu f000 0 eng c |
010 |
|
|
|a 88601418
|
019 |
|
|
|a 17602559
|
035 |
|
|
|a (OCoLC)18779227
|z (OCoLC)17602559
|
040 |
|
|
|a DGPO/DLC
|b eng
|c DLC
|d GPO
|d BTCTA
|d OCLCO
|d OCLCF
|d OCLCQ
|d VGM
|d WCM
|d OCLCQ
|
043 |
|
|
|a n-us---
|
049 |
|
|
|a COMA
|
050 |
0 |
0 |
|a HD9999.B443
|b U675 1988
|
074 |
|
|
|a 1025-A-1, 1025-A-2 (microfiche)
|
082 |
0 |
0 |
|a 338.4/76208/0973
|2 19
|
086 |
0 |
|
|a Y 4.Sci 2:100/K
|
088 |
|
|
|a Serial K (United States. Congress. House. Committee on Science, Space, and Technology)
|
110 |
1 |
|
|a United States.
|b Congress.
|b House.
|b Committee on Science, Space, and Technology.
|b Technology Policy Task Force.
|
245 |
1 |
0 |
|a Technology Policy Task Force hearing summary :
|b the commercial development of medical biotechnology : report /
|c prepared for the Technology Policy Task Force ; transmitted to the Committee on Science, Space, and Technology, House of Representatives, One Hundredth Congress, first session ; [prepared by Roc Ordman].
|
264 |
|
1 |
|a Washington :
|b U.S. G.P.O. :
|b For sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O.,
|c 1988.
|
300 |
|
|
|a v, 53 pages ;
|c 24 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent.
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia.
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier.
|
500 |
|
|
|a At head of title: Committee print.
|
500 |
|
|
|a Distributed to some depository libraries in microfiche.
|
500 |
|
|
|a Shipping list no.: 88-137-P.
|
500 |
|
|
|a "November 1987."
|
500 |
|
|
|a Hearing held July 29, 1987.
|
500 |
|
|
|a "Serial K."
|
500 |
|
|
|a Item 1025-A-1, 1025-A-2 (microfiche).
|
650 |
|
0 |
|a Biotechnology industries
|x Government policy
|z United States.
|
650 |
|
0 |
|a Medical innovations
|z United States.
|
650 |
|
7 |
|a Biotechnology industries
|x Government policy.
|2 fast.
|
650 |
|
7 |
|a Medical innovations.
|2 fast.
|
651 |
|
7 |
|a United States.
|2 fast.
|
700 |
1 |
|
|a Ordman, Roc.
|
710 |
1 |
|
|a United States.
|b Congress.
|b House.
|b Committee on Science, Space, and Technology.
|
740 |
0 |
|
|a Commercial development of medical biotechnology.
|
776 |
0 |
8 |
|i Online version:
|a United States. Congress. House. Committee on Science, Space, and Technology. Technology Policy Task Force.
|t Technology Policy Task Force hearing summary.
|d Washington : U.S.G.P.O. : For sale by the Supt. of Docs., Congressional Sales Office, U.S.G.P.O., 1988
|w (OCoLC)655019857.
|
907 |
|
|
|a .b61200207
|b cug
|c -
|d 200430
|e 230210
|
998 |
|
|
|a cug
|b 200430
|c m
|d a
|e -
|f eng
|g dcu
|h 0
|i 1
|
948 |
|
|
|a MARCIVE Overnight, in 2023.02
|
948 |
|
|
|a MARCIVE Overnight, 05/2020
|
994 |
|
|
|a C0
|b COM
|
995 |
|
|
|a Loaded with m2btab.ltiac in 2023.02
|
995 |
|
|
|a Loaded with m2btab.ltiac in 2020.05
|
995 |
|
|
|a Loaded with m2btab.b in 2020.04
|
989 |
|
|
|a Y 4.SCI 2:100/K
|d cusgh
|e - -
|f - -
|g -
|h 0
|i 0
|j 67
|k 200430
|l $0.00
|m
|n - -
|o -
|p 0
|q 0
|t 0
|x 0
|1 .i130210079
|